Table 2. Candidate gene expression and alterations in human prostate tumors.
Gene | % of prostate tumors with alteration (nā=ā218) | mRNA Upregulation | mRNA Downregulation | Amplification | Deletion |
AR | 15.1% | 18* | 4 | 15 | 0 |
AKT1 | 11.9% | 12 | 14 | 0 | 0 |
STRADA | 36.2% | 4 | 74 | 1 | 0 |
TTK | 18.4% | 33 | 4 | 0 | 3 |
4 of the samples with upregulated AR mRNA also had AR amplification.